Phase 4 Pulmonary Arterial Hypertension Clinical Trials
5 recruitingPhase 4
What is a Phase 4 trial?
Phase 4 trials, also called post-marketing studies, are conducted after a treatment has been approved and is available to the public. They monitor long-term effectiveness and safety in a broader population.
Showing 1–5 of 5 trials
Recruiting
Phase 4
A Study of Sotatercept for Patients With Eisenmenger Syndrome or Unrepaired Shunt-Associated Pulmonary Arterial Hypertension Resistant to Vasodilator Therapy
Eisenmenger SyndromePulmonary Arterial Hypertension of Congenital Heart Disease
Kazuya Hosokawa36 enrolled10 locationsNCT07356778
Recruiting
Phase 4
Right Ventricular Compensation With Sotatercept: A Prospective Single Arm Open Label Phase 4 Study to Evaluate the Effects of Sotatercept on Right Ventricular Function in Pulmonary Arterial Hypertension (RECOMPENSE)
Pulmonary Arterial HypertensionPulmonary Arterial Hypertension PAHPulmonary Arterial Hypertension WHO Group I
Amsterdam UMC, location VUmc20 enrolled1 locationNCT06658522
Recruiting
Phase 4
Pulmonary Hypertension: Intensification and Personalisation of Combination Rx
Pulmonary Arterial Hypertension
Sheffield Teaching Hospitals NHS Foundation Trust40 enrolled1 locationNCT05825417
Recruiting
Phase 4
Initial Triple Therapy Including Parenteral Treprostinil vs Initial Double Oral Therapy in PAH Group I Patients
Pulmonary Arterial Hypertension
AOP Orphan Pharmaceuticals AG110 enrolled19 locationsNCT06317805
Recruiting
Phase 4
Anti-CD20 Antibodies for Treatment of SLE-PAH
Pulmonary Arterial HypertensionSystemic Lupus Erythematosus
Chinese SLE Treatment And Research Group50 enrolled1 locationNCT05828147